Lyell Immunopharma, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Lyell Immunopharma, Inc. (LYEL) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$117.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-08-06
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-06-30 was -$117.00K.
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-03-31 was $0.00.
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-12-31 was $166.00K.
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-09-30 was $249.00K.
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2025 was -$3.34M.
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was -$1.34M.
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$1.51M.
- Lyell Immunopharma, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$103.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month as first filed | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$117.00K 10-Q · filed 2026-08-06 | $49.00K derived: sum of 3 quarters · filed 2026-08-06 | $298.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $166.00K derived: sum of 2 quarters · filed 2026-05-06 | $415.00K derived: sum of 3 quarters · filed 2026-05-06 | -$2.05M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $415.00K derived: sum of 2 quarters · filed 2026-03-12 | -$2.05M derived: sum of 3 quarters · filed 2026-08-06 | -$3.34M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.22M derived: sum of 2 quarters · filed 2026-08-06 | -$3.51M 10-Q · filed 2025-11-12 | -$4.43M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.76M 10-Q · filed 2026-08-06 | -$4.68M derived: sum of 3 quarters · filed 2026-08-06 | -$5.08M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$1.29M 10-Q · filed 2026-05-06 | -$2.21M derived: sum of 2 quarters · filed 2026-05-06 | -$2.62M derived: sum of 3 quarters · filed 2026-05-06 | -$2.62M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.33M derived: sum of 2 quarters · filed 2026-03-12 | -$1.33M derived: sum of 3 quarters · filed 2026-03-12 | -$1.34M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$402.00K derived: sum of 2 quarters · filed 2025-11-12 | -$417.00K 10-Q · filed 2025-11-12 | -$854.00K derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$15.00K 10-Q · filed 2025-08-12 | -$452.00K derived: sum of 3 quarters · filed 2026-03-12 | -$1.09M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-03-31 | -$15.00K 10-Q · filed 2025-05-13 | -$452.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.09M derived: sum of 3 quarters · filed 2026-03-12 | -$1.52M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2023-12-31 | -$437.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.08M derived: sum of 2 quarters · filed 2026-03-12 | -$1.51M derived: sum of 3 quarters · filed 2026-03-12 | -$1.51M 10-K · filed 2026-03-12 | |
| 2023-09-30 | -$642.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.07M derived: sum of 2 quarters · filed 2024-11-07 | -$1.07M 10-Q · filed 2024-11-07 | -$1.08M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | -$430.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$430.00K 10-Q · filed 2024-08-07 | -$436.00K derived: sum of 3 quarters · filed 2025-03-11 | -$449.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-06 | -$6.00K derived: sum of 2 quarters · filed 2025-03-11 | -$19.00K derived: sum of 3 quarters · filed 2025-03-11 | -$19.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2022-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$19.00K derived: sum of 2 quarters · filed 2025-03-11 | -$19.00K derived: sum of 3 quarters · filed 2025-03-11 | -$103.00K 10-K · filed 2025-03-11 | |
| 2022-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$13.00K derived: sum of 2 quarters · filed 2023-11-07 | -$97.00K 10-Q · filed 2023-11-07 | -$771.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$84.00K 10-Q · filed 2023-08-08 | -$758.00K derived: sum of 3 quarters · filed 2024-02-28 | -$970.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | -$84.00K 10-Q · filed 2023-05-04 | -$758.00K derived: sum of 2 quarters · filed 2024-02-28 | -$970.00K derived: sum of 3 quarters · filed 2024-02-28 | -$1.29M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | -$674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$886.00K derived: sum of 2 quarters · filed 2024-02-28 | -$1.21M derived: sum of 3 quarters · filed 2024-02-28 | -$1.21M 10-K · filed 2024-02-28 | |
| 2021-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$536.00K derived: sum of 2 quarters · filed 2022-11-08 | -$536.00K 10-Q · filed 2022-11-08 | -$496.00K 10-Q · filed 2021-11-12 | $4.35M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$324.00K 10-Q · filed 2022-08-04 | $4.56M derived: sum of 3 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $4.88M derived: sum of 2 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.88M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |